AAAAAA

   
Results: 1-14 |
Results: 14
A COMBINED MOLECULAR-DYNAMICS AB-INITIO STUDY OF H-2 ADSORPTION ON IDEAL, RELAXED, AND TEMPERATURE-RECONSTRUCTED MGO(111) SURFACES
Authors: HERMANSSON K BAUDIN M ENSING B ALFREDSSON M WOJCIK M
Citation: K. Hermansson et al., A COMBINED MOLECULAR-DYNAMICS AB-INITIO STUDY OF H-2 ADSORPTION ON IDEAL, RELAXED, AND TEMPERATURE-RECONSTRUCTED MGO(111) SURFACES, The Journal of chemical physics, 109(17), 1998, pp. 7515-7521
STRESSFUL LIFE EVENTS AS POTENTIAL TRIGGERS OF PEMPHIGUS
Authors: CREMNITER D BAUDIN M ROUJEAU JC PROST C CONSOLI SG FRANCES C CHOSIDOW O
Citation: D. Cremniter et al., STRESSFUL LIFE EVENTS AS POTENTIAL TRIGGERS OF PEMPHIGUS, Archives of dermatology, 134(11), 1998, pp. 1486-1487
A MOLECULAR-DYNAMICS STUDY OF MGO(111) SLABS
Authors: BAUDIN M WOJCIK M HERMANSSON K
Citation: M. Baudin et al., A MOLECULAR-DYNAMICS STUDY OF MGO(111) SLABS, Surface science, 375(2-3), 1997, pp. 374-384
SUPPORTING JIT WITH THE BEST WAGE SYSTEM
Authors: BAUDIN M
Citation: M. Baudin, SUPPORTING JIT WITH THE BEST WAGE SYSTEM, IIE solutions, 28(2), 1996, pp. 30-35
NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1,RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A EUROPEAN PHASE-II TRIAL
Authors: SANDER O RAU R VANRIEL P VANDEPUTTE L HASLER F BAUDIN M LUDIN E MCAULIFFE T DICKINSON S KAHNY MR LESSLAUER W VANDERAUWERA P
Citation: O. Sander et al., NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1,RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A EUROPEAN PHASE-II TRIAL, Arthritis and rheumatism, 39(9), 1996, pp. 1288-1288
CHRONIC TNF NEUTRALIZATION (UP TO 1-YEAR) BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF AN OPEN-LABEL EXTENSION OF A DOUBLE-BLIND SINGLE-DOSE PHASE-I STUDY
Authors: HASLER F VANDEPUTTE L BAUDIN M LUDIN E DURRWELL L MCAULIFFE T VANDERAUWERA P
Citation: F. Hasler et al., CHRONIC TNF NEUTRALIZATION (UP TO 1-YEAR) BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF AN OPEN-LABEL EXTENSION OF A DOUBLE-BLIND SINGLE-DOSE PHASE-I STUDY, Arthritis and rheumatism, 39(9), 1996, pp. 1292-1292
MONTHLY VS BIMONTHLY DOSING OF LENERCEPT (TNFR55-IGG1, RO-45-2081) INPATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A DOUBLE-BLIND CONTROLLED PHASE-II TRIAL
Authors: RAN R SANDER O SCHATTENKIRCHNER M BAUDIN M SIEHR U BISSCHOPS C VANDERAUWERA P
Citation: R. Ran et al., MONTHLY VS BIMONTHLY DOSING OF LENERCEPT (TNFR55-IGG1, RO-45-2081) INPATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A DOUBLE-BLIND CONTROLLED PHASE-II TRIAL, Arthritis and rheumatism, 39(9), 1996, pp. 1293-1293
LOADING MAINTENANCE DOSES APPROACH TO NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A DOUBLEBLIND PLACEBO-CONTROLLED PHASE-II TRIAL/
Authors: CUTOLO M KIRKHAM B BOLOGNA C SANY J SCOTT D BROOKS P FORRE O JAIN R KVIEN T MARKENSON J SEIBOLD J STURROCK R VEYS E EDWARDS J ZAUG M DURRWELL L BISSCHOPS C CLAIR PS MILNARIK P BAUDIN M VANDERAUWERA P
Citation: M. Cutolo et al., LOADING MAINTENANCE DOSES APPROACH TO NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A DOUBLEBLIND PLACEBO-CONTROLLED PHASE-II TRIAL/, Arthritis and rheumatism, 39(9), 1996, pp. 1294-1294
NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1 RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF AN US PHASE-II TRIAL
Authors: FURST D WEISMAN M PAULUS H BULPITT K WEINBLATT M POLISSON R CLAIR PS MILNARIK P BAUDIN M LUDIN E MCAULIFFE T KAHNY MR LESSLAUER W VANDERAUWERA P
Citation: D. Furst et al., NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1 RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF AN US PHASE-II TRIAL, Arthritis and rheumatism, 39(9), 1996, pp. 1295-1295
INHIBITOR OF THE RELEASE OF MAST-CELL MEDIATORS DOES NOT IMPROVE THE PSORIATIC PLAQUE
Authors: VANDEKERKHOF PCM GOOS M CHRISTOPHERS E BAUDIN M DUPUY P
Citation: Pcm. Vandekerkhof et al., INHIBITOR OF THE RELEASE OF MAST-CELL MEDIATORS DOES NOT IMPROVE THE PSORIATIC PLAQUE, Skin pharmacology, 8(1-2), 1995, pp. 25-29
TERATOGENIC RISK WITH ETRETINATE AND ACITRETIN TREATMENT
Authors: GEIGER JM BAUDIN M SAURAT JH
Citation: Jm. Geiger et al., TERATOGENIC RISK WITH ETRETINATE AND ACITRETIN TREATMENT, Dermatology, 189(2), 1994, pp. 109-116
ACITRETIN IN THE TREATMENT OF SEVERE LICHEN-SCLEROSUS-ET-ATROPHICUS OF THE VULVA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Authors: BOUSEMA MT ROMPPANEN U GEIGER JM BAUDIN M VAHAESKELI K VARTIAINEN J VUOPALA S
Citation: Mt. Bousema et al., ACITRETIN IN THE TREATMENT OF SEVERE LICHEN-SCLEROSUS-ET-ATROPHICUS OF THE VULVA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Journal of the American Academy of Dermatology, 30(2), 1994, pp. 225-231
NEUROPSYCHOLOGICAL ABNORMALITIES IN SJOGRENS-SYNDROME
Authors: BELIN C MORONI C CAILLATVIGNERON N DUMAS JL BAUDIN M GUILLEVIN L
Citation: C. Belin et al., NEUROPSYCHOLOGICAL ABNORMALITIES IN SJOGRENS-SYNDROME, Neurology, 44(4), 1994, pp. 10000276-10000276
TOPICAL TIACRILAST, A POTENT MAST-CELL DEGRANULATION INHIBITOR, DOES NOT IMPROVE ADULT ATOPIC ECZEMA
Authors: CZARNETZKI BM BRECHTEL B BRAUNFALCO O CHRISTOPHERS E SCHOPF E RECKERSCZASCHKA R BAUDIN M DUPUY P
Citation: Bm. Czarnetzki et al., TOPICAL TIACRILAST, A POTENT MAST-CELL DEGRANULATION INHIBITOR, DOES NOT IMPROVE ADULT ATOPIC ECZEMA, Dermatology, 187(2), 1993, pp. 112-114
Risultati: 1-14 |